BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 26634305)

  • 1. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
    Kristensen V; Malmstrøm GH; Skar V; Røseth A; Moum B
    Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.
    Lasson A; Stotzer PO; Öhman L; Isaksson S; Sapnara M; Strid H
    J Crohns Colitis; 2015 Jan; 9(1):26-32. PubMed ID: 25008478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods.
    Kristensen V; Lauritzen T; Jelsness-JØrgensen LP; Moum B
    Scand J Clin Lab Invest; 2015 Sep; 75(5):355-61. PubMed ID: 25856663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin.
    Kristensen V; Klepp P; Cvancarova M; Røseth A; Skar V; Moum B
    J Crohns Colitis; 2015 Feb; 9(2):164-9. PubMed ID: 25518057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
    Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time.
    Amcoff K; Stridsberg M; Lampinen M; Magnuson A; Carlson M; Halfvarson J
    Scand J Gastroenterol; 2017 Mar; 52(3):344-350. PubMed ID: 27881032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
    Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of faecal immunochemical testing as an alternative to faecal calprotectin in children.
    Sandhu K; Naik S; Ayling RM
    Ann Clin Biochem; 2021 May; 58(3):230-235. PubMed ID: 33412889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
    Summerton CB; Longlands MG; Wiener K; Shreeve DR
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12.
    Whitehead SJ; Ford C; Gama RM; Ali A; McKaig B; Waldron JL; Steed H; Brookes MJ
    J Clin Pathol; 2017 Dec; 70(12):1049-1056. PubMed ID: 28735301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-performed extraction of faecal calprotectin.
    Kristensen V; Lauritzen T; Jelsness-Jørgensen LP; Frigstad SO; Corwin C; Moum B
    Clin Chem Lab Med; 2016 Aug; 54(8):1357-63. PubMed ID: 26812797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study.
    Cremer A; Ku J; Amininejad L; Bouvry MR; Brohet F; Liefferinckx C; Devière J; van Gossum A; Smet J; Stordeur P; Franchimont D
    J Crohns Colitis; 2019 Oct; 13(11):1372-1379. PubMed ID: 30944925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
    Heida A; Knol M; Kobold AM; Bootsman J; Dijkstra G; van Rheenen PF
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1742-1749.e2. PubMed ID: 28606846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
    Lee YW; Lee KM; Lee JM; Chung YY; Kim DB; Kim YJ; Chung WC; Paik CN
    Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.
    Burri E; Beglinger C
    Swiss Med Wkly; 2012; 142():w13557. PubMed ID: 22481443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.